DAYTON CHILDRENS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.5M
- Transactions
- 330
- Companies
- 35
- Average per transaction
- $4,424
Who reported the payments
| Vertex | $849,977 |
| Jazz Pharmaceuticals Inc. | $257,330 |
| Novo Nordisk AS | $59,615 |
| Pfizer | $41,173 |
| Merck | $39,460 |
| Insulet Corporation | $33,025 |
| Stryker | $30,041 |
| Ipsen Biopharmaceuticals, Inc | $23,673 |
| Carl Zeiss Meditec USA, Inc. | $17,206 |
| Janssen Research & Development, LLC | $14,300 |
| Incyte Corporation | $12,838 |
| Kls-martin L.p. | $11,437 |
| Johnson & Johnson | $9,754 |
| Bioverativ Therapeutics Inc. | $9,560 |
| Siemens Medical Solutions USA, Inc. | $6,890 |
| Medline Industries LP | $5,000 |
| Shionogi Inc | $4,754 |
| AbbVie | $4,676 |
| GSK | $4,526 |
| Zimmer Biomet | $4,515 |
| Smith+Nephew | $4,500 |
| Eli Lilly | $4,272 |
| Boston Scientific | $3,141 |
| KARL Storz Endoscopy-america | $1,738 |
| Medtronic | $1,500 |
| E.r. Squibb & Sons, L.L.C. | $1,200 |
| Vivus LLC | $1,016 |
| Masimo Corporation | $787 |
| GE HealthCare | $699 |
| AstraZeneca | $480 |
| Abbott | $416 |
| Teva Pharmaceuticals USA, Inc. | $205 |
| B. Braun Medical Inc. | $170 |
| Cochlear Americas | $90 |
| CSL Behring | $15 |